Human medicines European public assessment report (EPAR): Tofidence, tocilizumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Tofidence, tocilizumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised

Orphan designation: recombinant human N-acetylgalactosamine-6-sulfatase (elosulfase alfa) Treatment of mucopolysaccharidosis, type IVA (Morquio A syndrome), 24/07/2009 Withdrawn

Orphan designation: recombinant human N-acetylgalactosamine-6-sulfatase (elosulfase alfa) Treatment of mucopolysaccharidosis, type IVA (Morquio A syndrome), 24/07/2009 Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness